Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Interferon beta-1b Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 3 2
Excel (.xslx) CSV (.csv)